161 related articles for article (PubMed ID: 34001286)
1. The World Health Organization road map for neglected tropical diseases 2021-2030: implications for onchocerciasis elimination programs.
Vieri MK; Logora MY; Rafiq K; Colebunders R
Infect Dis Poverty; 2021 May; 10(1):70. PubMed ID: 34001286
[TBL] [Abstract][Full Text] [Related]
2. Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan: a 3-year longitudinal, prospective, population-based study.
Jada SR; Amaral LJ; Lakwo T; Carter JY; Rovarini J; Bol YY; Logora MY; Hadermann A; Hopkins A; Fodjo JNS; Colebunders R
Lancet Glob Health; 2023 Aug; 11(8):e1260-e1268. PubMed ID: 37474232
[TBL] [Abstract][Full Text] [Related]
3. Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
Turner HC; Walker M; Churcher TS; Osei-Atweneboana MY; Biritwum NK; Hopkins A; Prichard RK; Basáñez MG
Clin Infect Dis; 2014 Oct; 59(7):923-32. PubMed ID: 24944228
[TBL] [Abstract][Full Text] [Related]
4. An appraisal of the neglected tropical diseases control program in Cameroon: the case of the national program against onchocerciasis.
Njim T; Aminde LN
BMC Public Health; 2017 Jan; 17(1):103. PubMed ID: 28109269
[TBL] [Abstract][Full Text] [Related]
5. African Programme for Onchocerciasis Control: progress report, 2013-2014.
Wkly Epidemiol Rec; 2014 Dec; 89(49):551-60. PubMed ID: 25485343
[No Abstract] [Full Text] [Related]
6. Socioeconomic impacts of elimination of onchocerciasis in Abu-Hamed focus, northern Sudan: lessons after elimination.
Ahmed A; Elbashir A; Mohamed AA; Alim AA; Mubarak A; Abdelrahman D; Mohammed E; Mohamed NS; Elaagip AH; Zarroug IMA; Mounkaila N; Tahir H
BMC Res Notes; 2020 May; 13(1):256. PubMed ID: 32456708
[TBL] [Abstract][Full Text] [Related]
7. Cross-border collaboration for neglected tropical disease efforts-Lessons learned from onchocerciasis control and elimination in the Mano River Union (West Africa).
Gustavsen K; Sodahlon Y; Bush S
Global Health; 2016 Aug; 12(1):44. PubMed ID: 27549911
[TBL] [Abstract][Full Text] [Related]
8. From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
Colebunders R; Siewe Fodjo JN; Hopkins A; Hotterbeekx A; Lakwo TL; Kalinga A; Logora MY; Basáñez MG
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007407. PubMed ID: 31318857
[No Abstract] [Full Text] [Related]
9. Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope.
Masiyiwa T; Bockarie MJ
Int J Infect Dis; 2024 Mar; 140():102-103. PubMed ID: 38280664
[No Abstract] [Full Text] [Related]
10. "Cross-border collaboration in onchocerciasis elimination in Uganda: progress, challenges and opportunities from 2008 to 2013".
Lakwo T; Ukety T; Bakajika D; Tukahebwa E; Awaca P; Amazigo U
Global Health; 2018 Feb; 14(1):16. PubMed ID: 29409509
[TBL] [Abstract][Full Text] [Related]
11. Assessing Onchocerciasis Subcriticality from Pre-Intervention Cross-Sectional Surveys.
Kelly JD; Rebollo Polo M; Marie Zoure HG; Oldenburg CE; Keenan JD; Porco TC; Lietman TM
Am J Trop Med Hyg; 2020 Jul; 103(1):287-294. PubMed ID: 32458796
[TBL] [Abstract][Full Text] [Related]
12. Scientists celebrate successes, new tools in fight against human parasitic worms.
Kuehn BM
JAMA; 2013 Jul; 310(1):19-20. PubMed ID: 23821071
[No Abstract] [Full Text] [Related]
13. 681 Progress report on the elimination of human onchocerciasis, 2016–2017.
Wkly Epidemiol Rec; 2017 Nov; 92(45):681-94. PubMed ID: 29130679
[No Abstract] [Full Text] [Related]
14. Preventive chemotherapy as a strategy for elimination of neglected tropical parasitic diseases: endgame challenges.
Bockarie MJ; Kelly-Hope LA; Rebollo M; Molyneux DH
Philos Trans R Soc Lond B Biol Sci; 2013 Aug; 368(1623):20120144. PubMed ID: 23798692
[TBL] [Abstract][Full Text] [Related]
15. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
[TBL] [Abstract][Full Text] [Related]
16. Global programme to eliminate lymphatic filariasis: progress report, 2016.
Wkly Epidemiol Rec; 2017 Oct; 92(40):594-607. PubMed ID: 28984121
[No Abstract] [Full Text] [Related]
17. African Programme for Onchocerciasis Control: progress report, 2014–2015.
Wkly Epidemiol Rec; 2015 Dec; 90(49):661-74. PubMed ID: 26638222
[No Abstract] [Full Text] [Related]
18. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
[TBL] [Abstract][Full Text] [Related]
19. Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda.
Colebunders R; Hendy A; Mokili JL; Wamala JF; Kaducu J; Kur L; Tepage F; Mandro M; Mucinya G; Mambandu G; Komba MY; Lumaliza JL; van Oijen M; Laudisoit A
BMC Res Notes; 2016 Mar; 9():182. PubMed ID: 27005304
[TBL] [Abstract][Full Text] [Related]
20. Progress toward elimination of onchocerciasis in the Americas.
Sauerbrey M; Rakers LJ; Richards FO
Int Health; 2018 Mar; 10(suppl_1):i71-i78. PubMed ID: 29471334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
